1. Home
  2. BKKT vs STXS Comparison

BKKT vs STXS Comparison

Compare BKKT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bakkt Holdings Inc.

BKKT

Bakkt Holdings Inc.

HOLD

Current Price

$8.19

Market Cap

212.4M

Sector

Technology

ML Signal

HOLD

Logo Stereotaxis Inc.

STXS

Stereotaxis Inc.

HOLD

Current Price

$1.85

Market Cap

177.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKKT
STXS
Founded
2018
1990
Country
United States
United States
Employees
48
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
212.4M
177.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
BKKT
STXS
Price
$8.19
$1.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$21.50
$4.00
AVG Volume (30 Days)
1.2M
334.2K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$29,346,617.00
Revenue This Year
N/A
$28.22
Revenue Next Year
$261.39
$30.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.87
$1.67
52 Week High
$49.79
$3.59

Technical Indicators

Market Signals
Indicator
BKKT
STXS
Relative Strength Index (RSI) 45.23 44.33
Support Level $8.03 $1.74
Resistance Level $10.51 $1.95
Average True Range (ATR) 0.58 0.09
MACD 0.16 0.02
Stochastic Oscillator 59.28 35.85

Price Performance

Historical Comparison
BKKT
STXS

About BKKT Bakkt Holdings Inc.

Bakkt Inc builds digital financial infrastructure designed to support institutional participation in the digital asset economy. The company platform is built to accommodate various digital assets and offers its clients the flexibility to build a product that aligns with its vision and customers' needs. Its services include Bakkt Markets, Bakkt Agent, Bakkt Global.

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

Share on Social Networks: